Announcement on Convening the 2026 Semi-annual Performance and Cash Dividend Briefing
Securities code: 603367 Securities abbreviation: Chenxin Pharmaceutical Announcement number: 2026-026
Chenxin Pharmaceutical Co., Ltd.
Announcement on convening the 2026 semi-annual results and cash dividend briefing meeting
The company's board of directors and all directors guarantee that the contents of this announcement do not contain any false records, misleading statements or major omissions, and assume legal responsibility for the authenticity, accuracy and completeness of its contents.
Important content reminder:
Meeting time: 9:00-10:00 am on September 2, 2026 (Wednesday)
Meeting location: Shanghai Stock Exchange Roadshow Center (Website: http://roadshow.sseinfo.com/)
Meeting method: Shanghai Securities Roadshow Center online interaction
Investors can log in to the homepage of the SSE Roadshow Center website before 16:00 on August 31, 2026, and click on the "Question Pre-Collection" column or ask questions through the email address of Chenxin Pharmaceutical Co., Ltd. (hereinafter referred to as the "Company") at [email protected]. The company will answer questions of common concern to investors at the briefing meeting.
The company has released the company's "2026 Semi-Annual Report" on August 25, 2026. In order to facilitate investors to have a more comprehensive and in-depth understanding of the company's operating results and financial status in the 2026 half-year, the company plans to hold a 2026 semi-annual performance and cash dividend briefing on September 2, 2026 (Wednesday) from 9:00-10:00 am to communicate on issues of concern to investors.
1. Type of briefing session
This investor briefing will be held in an interactive online format. The company will interact and communicate with investors on the specific operating results and financial indicators for the first half of 2026, and answer questions of common concern to investors within the scope permitted by information disclosure.
2. Time and place of the briefing meeting
(1) Meeting time: 9:00-10:00 am on September 2, 2026 (Wednesday)
(2) Meeting location: Shanghai Stock Exchange Roadshow Center (Website: http://roadshow.ss einfo.com/)
(3) Meeting method: SSE Roadshow Center online interaction
3. Participants
Chairman and general manager Mr. Du Zhenxin, financial director and board secretary Mr. Xu Xinbing, independent director Mr. Cai Wenchun and staff of the securities department (if there are special circumstances, the number of participants may be adjusted).
4. How to participate as an investor
(1) Investors can log in to the SSE Roadshow Center (http://roadshow.sseinfo.com/) via the Internet from 9:00 to 10:00 a.m. on September 2, 2026 (Wednesday) to participate in this annual performance and cash dividend briefing online. The company will answer investors' questions in a timely manner.
(2) Investors can log on to the homepage of the Shanghai Securities Roadshow Center website before 16:00 on August 31, 2026 (Monday) and click on the "Question Pre-Collection" column or ask questions through the company's email [email protected] om. The company will answer questions of common concern to investors at the briefing meeting.
5. Contact person and consultation method
Contact person: Sun Wei
Tel: 0537-2989906
Email: [email protected]
6. Other matters
After the 2026 semi-annual results and cash dividend briefing organized by the company is held, investors can check the holding status and main content of this investor briefing through the SSE Roadshow Center (http://roadshow.sseinfo.com/).
Announcement is hereby made.
Board of Directors of Chenxin Pharmaceutical Co., Ltd.
August 24, 2026